Therapeutic Psilocybin Proposal Advanced By Massachusetts Lawmakers

Lawmakers in the Massachusetts Joint Committee on Public Health advanced a proposal this week that would legalize psilocybin — the psychedelic compound in so-called “magic mushrooms” —  for medical, therapeutic, and spiritual purposes, Marijuana Moment reports.

Sponsored by Rep. Nicholas A. Boldyga (R), proposed bill H.3605 would allow the supervised use of psilocybin during sessions overseen “by a properly licensed facilitator.”

Under the bill, the state Department of Public Health would be in charge of licensing the program’s facilitators as well as the educational institutions where facilitators would be trained, and other regulations related to the program. Facilitators would be charged a $155 biennial licensing fee and would be required to complete between 20 and 300 hours of training from a licensed school, including at least 20 hours of in-person practice. Facilitators would also need to be high school graduates, residents of Massachusetts, aged 21+, and free of felonies for the past five years before they can apply for the program, the report said.

The proposal comes as advocates for psychedelics reform recently submitted signatures for a 2024 Massachusetts ballot proposal that, if approved by voters, would legalize psilocybin as a treatment for anxiety, depression, and PTSD, according to a CBS News report.

Massachusetts activist organization Bay Staters for Natural Medicine expressed support for the proposal. “The PAC can no longer claim that the only choice before voters is an unelected control commission to draft expensive regulations or no legalization at all. That was always a false choice, and we’re grateful that H.3605 passing out of its committee puts that on full display” said Michael Botelho, a cofounder of New England Veterans for Plant Medicine and a Massachusetts Marine Corp Veteran.

Oregon was the first state to legalize medicinal psilocybin following a successful voter initiative in 2020, and the very first state-licensed psilocybin treatment center in the U.S. opened for business in Eugene, Oregon last year. However, many advocates have pointed out that Oregon’s high licensing registration costs for practictioners (which amount to more than 20 times the fees proposed under H.3605) could result in treatments being inaccessible to people in need. Massachusetts’ bill would create a much more inclusive framework for psilocybin therapists to serve a broader range of patients.

End


Bitcoin: the Obvious Financial System for a Thriving Cannabis Industry

Editor’s note: this article is a guest contribution from Alan, founder of Strainly.

The world has experienced an unprecedented consolidation of power and wealth in recent years, with big government, big banks, and big pharma all working together to concentrate ever more power and attack households and family businesses. At the very core of this issue lies money. Or rather, monetary policy. Why? Let’s dive in.

Ever More Concerning Power Grabs

The problems faced by the cannabis industry predate the COVID-19 era. The cannabis community has always been concerned about corporate takeovers and consolidation, even before legalization occurred. Many in the industry have feared that it could become a manifestation of big agriculture, big tobacco, and big pharma. This fear is becoming a reality, as consolidation is happening right before our eyes and many feel powerless to stop it. Access to basic financial services has been a struggle for many in the industry, and as a result, a parallel financial system has emerged as an alternative to the broken legacy system.

A Broken System

The legacy system, based on fiat currency, is controlled by central banks and creates money out of thin air. This system unfairly distributes wealth, with the majority going to insiders while the rest struggle to survive and pay interests to those in power. Since the end of the gold standard in 1971, the purchasing power of fiat currencies such as the US dollar has significantly decreased. This has led to consumers and businesses taking on more credit to acquire the assets they need, which can be extremely challenging for cannabis industry businesses. Add to that the additional regulatory burdens faced by cannabis businesses, and we’ve created an environment where small and family-run businesses have to struggle immensely to even stay afloat, let alone turn a profit.

The fiat system is closely tied to the principle of proprietary ownership, where innovators seek exclusive rights over their “intellectual property” and any of its derivatives to prevent anyone else from profiting from or modifying their work. In the context of cannabis, this system incentivizes breeders to limit access to their cultivars and restricts other breeders from improving the genetic pool, ultimately leading to a destruction of biodiversity. It also leads to predatory practices against farmers who inadvertently breach patents by being cross-pollinated by proprietary varieties. The fiat system, along with predatory proprietary practices, hampers innovation while consolidation prevails, as smaller businesses struggle to compete in a system controlled by corporations. This system is undeniably penetrating the cannabis industry, as I have been writing for many years.

The industry has been consolidating at an alarming rate, with debt-ridden corporations and cronies pushing legacy farms out of the market while flooding it with low-quality products. This race to the bottom is a direct result of the fiat-based market system, which encourages consolidation and does not favor high-quality craft products. Small-scale craft producers often struggle to thrive in a system that demands economies of scale and unattainable compliance requirements. Instead of consolidating the cannabis industry based on capital expenditure, I’d argue that a Bitcoin-centric industry would reward craft producers based on the quality they bring to the market, rather than the size of their operations. How?

A New Paradigm: Money Limited in Quantity, Just Like Nature

While many may still view cryptocurrencies with skepticism, I am convinced that using “sound money”–specifically Bitcoin–addresses a lot of the issues described above. Sound money is limited in quantity and therefore maintains its value over time, thus rewarding hard work and innovation. Bitcoin, as a decentralized and limited currency, offers a viable alternative to fiat money. It separates money from the State and corrupt politicians and central bankers, while securing transactions between parties without the need for intermediaries. Bitcoin is not subject to the inflationary pressures of fiat currencies and is designed to increase scarcity over time, rewarding delayed gratification and long-term thinking.

By using Bitcoin, breeders and growers can be paid in a currency that allows them to focus on their craft without the need to engage in patent wars or defend intellectual property.

Unlike the corporate agricultural behemoths who patent crop genetics and then sue neighboring farmers when their fields get cross-pollinated, when it comes to cannabis, open-source breeding is arguably the most suitable intellectual property (IP) strategy for small breeders and farmers. Engaging in patent wars with limited resources is often a losing battle, simply because obtaining a plant patent on your strain (as a breeder) does not actually prevent anyone from using your genetics. It merely gives you legal grounds to pay a law firm and take the infringer to court, which implies that you have cash set aside, raised money from investors or loans from banks. If the other party has deep pockets, it’s very easy to bankrupt you through legal proceedings. They literally turn your IP against you. It’s a game where the party that is ultimately closest to that “easy money” printer (through subsidies and tax credits, investments, or loans) always wins.

Bitcoin provides an alternative solution by allowing breeders and growers to be paid in a currency that appreciates in value and preserves the value of their hard work. Hard money. It protects their anonymity and enables them to transact with anyone in the world, without the need for permission from intermediaries. Bitcoin provides breeders the opportunity to focus on their craft and generate revenue based on the desirability of their genetics, rather than defending intellectual property to collect perpetual rents. Because breeders and growers should not be aiming to find ways to get closer to the money printer to thrive.

In addition to promoting financial autonomy, Bitcoin also addresses the issue of transaction settlement, which has been a central problem for legal cannabis businesses that have been excluded from the traditional banking system. Many of these businesses have had to rely on cash transactions, which come with practical and security challenges. Bitcoin’s trustless and instant transaction settlement between parties provides a more secure and efficient way to transact, without relying on banks or payment processors. This removes the need to pay (often outrageous) processing fees and allows businesses to be self-reliant rather than depending on financial institutions that have historically been hostile towards the cannabis industry.

Conclusion

Strainly has been using bitcoin as our only payment gateway for over a year, and we have found that being a bitcoin-only business is not only feasible, but empowering.

Of course, it pays to be cautious, and skeptics will undoubtedly be nervous about widely-publicized price swings and “crashes” in the crypto markets over the past few years. The fact that Bitcoin is still in its early stages of adoption and is not yet widely used as a medium of exchange or store of value contributes to its volatility. It’s existed for only 15 years and is the only truly decentralized form of money, which can lead to more pronounced price movements as there is no entity to stabilize the market. As more people become aware of and use Bitcoin, its price should become less volatile. It’s worth noting that since its inception, however, bitcoin has appreciated more than any other asset, by far.

In conclusion, I believe that Bitcoin is the natural fit for the cannabis industry. If you believe in decentralization, open-source technology, resilience, and biodiversity, Bitcoin aligns perfectly with these values. It offers a sound money system that promotes financial autonomy, equitable distribution of wealth (that has to be earned and cannot be printed out of thin air), which ultimately protects biodiversity by fostering low time preference, or in other words, a long term vision. It addresses transaction settlement and allows breeders and growers to be rewarded for their hard work, focusing on quality rather than engaging in patent wars and defending artificial moats. Ultimately, bitcoin empowers businesses to be self-reliant, free from the constraints of the broken financial system.

End


Idaho Bill Would Ban Advertisements for Out-of-State Cannabis

Idaho lawmakers are set to consider a proposal to ban the advertising of illegal products after a state lawmaker saw billboards advertising out-of-state cannabis products, Idaho Capital Sun reports.

The proposal, co-sponsored by Rep. Judy Boyle (R) and Sen. Chris Trakel (R), would allow misdemeanor charges against anyone who “willfully publishes any notice or advertisement, in any medium, of a product or service that is illegal under Idaho law,” the report said. Proponents of the bill referenced witnessing specific instances of cannabis being advertised in Idaho including a billboard near the Idaho-Oregon border, on another billboard in downtown Boise,  and in newspaper advertisements.

“And then another individual sent me — actually on the internet — that you can have drugs delivered to your Idaho doorstep. So I thought this was a little outrageous.” — Boyle, via the Idaho Capital Sun

The bill — which, if passed, would take effect immediately — was introduced on Wednesday to the House State Affairs Committee.

Idaho is one of the last remaining states to maintain a complete prohibition on cannabis but the majority of its neighboring states — Montana, Nevada, Oregon, and Washington — have passed adult-use cannabis legalization laws. Of Idaho’s other neighbors, cannabis is also prohibited in Wyoming but legal for medical use in Utah (and federally legal in Canada).

End


Pennsylvania Gov. Calls for Legalizing Adult-Use Cannabis

Pennsylvania Gov. Josh Shapiro (D) called this week for the legalization of adult-use cannabis after suggesting the state is losing out on potential cannabis revenues to neighboring states that have already legalized, the Philadelphia Inquirer reports.

The governor signaled his priority on the issue on Tuesday by including legalization in his $48.3 billion budget proposal. An administration official predicted that with a 20% tax rate on regulated cannabis products, the state could generate $14.8 million in tax revenue during the first year, increasing to $76 million in its second, $160 million in its third, and $230 million in its fourth year of a regulated adult-use cannabis market, according to the report.

Pennsylvania‘s neighbors in New York, New Jersey, Delaware, Maryland, and Ohio have already legalized adult-use cannabis and Shapiro argues that the state is falling behind.

“Let’s stop hamstringing ourselves and start competing.” — Shapiro, via the Philadelphia Inquirer

The state’s Republican leadership, which controls the state Senate, has historically opposed significant cannabis reforms but this week suggested they may be willing the consider the proposal, the report said.

“We also need to understand where the governor is coming from,” said Senate Majority Leader Joe Pittman (R).

A Pennsylvania poll found last July that just over half of the state’s voters support legalizing adult-use cannabis, slightly down from a previous poll which placed support at 56%.

End


EU Officials Approve Initiative on Medical Cannabis Access, Research

Officials with the European Commission this week partially approved the launch of the ‘European Cannabis Initiative,’ which is a multi-national ballot initiative seeking to improve medical cannabis access in the European Union (EU) and boost cannabis research opportunities.

The commission approved the initiative to cover two out of the three requests made by advocates:

  • That the initiative would “foster access to medical cannabis and allow the transportation of cannabis and its derivatives prescribed for therapeutic purposes to ensure the full enjoyment of the right to health; and
  • That the initiative serves to “allocate the necessary resources for researching cannabis for its therapeutic purposes.”

Advocates had also called for the initiative to “convene a trans-European citizens’ assembly on cannabis policies” that would have included sanctions and established consistency among member nations’ cannabis policies, but the commission ultimately rejected this request.

“The Commission had to refuse the registration of the first objective of the initiative, as it falls outside the Commission’s powers to submit a proposal for a legal act on this matter,” officials wrote.

Following Tuesday’s approval, advocates now have six months to launch their signature collection efforts. If the petition can garner at least one million supporting signatures from at least seven different EU member nations, the European Commission will be forced “to take action in response to the request or not and will be required to explain its reasoning.”

The approval follows the recent announcement that lawmakers in Germany — which is the EU’s largest economy — have reached a final deal to legalize adult-use cannabis, with possession and home cultivation expected to become federally legal there starting April 1.

End


Massachusetts Sets New Annual $1.56B Cannabis Sales Record

Massachusetts cannabis dispensaries set a new annual sales record in 2023 at $1.56 billion, according to data from the Cannabis Control Commission (CCC) outlined by Boston 25 News.

The year was capped off with the industry’s most lucrative month yet after licensed retailers sold $140.1 million worth of adult-use cannabis products in December, breaking the previous monthly sales record from August 2023. Regulators said the state is tracking 338 dispensaries and 21 cannabis delivery companies. Ultimately, annual cannabis sales increased last year by $78 million, or about 5%.

Despite the gains last year, the Massachusetts cannabis industry experienced a tumultuous 2023 following the sudden removal of CCC Chair Shannon O’Brien in September — who in turn sued the state treasurer over the decision. Then two more top CCC officials were suspended in December, which sent the agency into further disarray and prompted lawmakers to call for an investigation into the agency.

CCC Acting Chair Ava Concepcion said in the report that the state’s cannabis industry is “still a maturing market.”

“This continued growth confirms that Massachusetts’ regulated marijuana industry is still a maturing market,” said the acting CCC Chair Ava Concepcion.

“As more retailers and delivery licensees come online, flower prices start to stabilize, and the stigma surrounding cannabis slowly dissipates — legal, tested products are becoming more accessible, affordable, and approachable than ever before, and that’s reflected in the multiple sales records licensees broke in 2023.” — Concepcion, via Boston 25 News

Massachusetts voters approved cannabis legalization in 2016 and the state’s adult-use industry was launched in 2018. Sales have continued to grow each year and the state is on track to surpass more than $6 billion in total adult-use cannabis sales sometime this year.

End


Multiple Cannabis Legalization Proposals Filed In Hawaii

Hawaii lawmakers have multiple options for adult-use cannabis reforms before them following the introduction of three different cannabis bills so far this legislative session.

Introduced late last month, a pair of companion bills brought by House Rep. David Tarnas (D) and Sen. Jarrett Keohokalole (D) closely resemble a legalization proposal unveiled late last year by Hawaii Attorney General Anne Lopez, according to Marijuana Moment. Those proposals (HB2600 and SB3335) would legalize adult-use cannabis and establish the Hawaii Cannabis Authority, which would oversee sales and other regulatory considerations.

Some advocates, however, argue that the proposals could do more harm than good by introducing new cannabis possession penalties for minors.

“Generally speaking, the bill provides a sound floorplan for adult-use legalization but erects a structure that is still far too punitive in its approach. Placing a velvet glove of legalization on law enforcement’s iron hand is not what is called for.” — Nikos Leverenz, of the Drug Policy Forum of Hawai’i and the Hawai’i Health and Harm Reduction Center, via Marijuana Moment

Lawmakers could also take up two other cannabis reform bills as outlined by Cannabis Business Report:

  • Senate Bill 2487, proposed by Sen. Joy San Buenaventura (D), seeks to decriminalize the adult possession of up to one ounce of cannabis, reclassifying possession “offenses” as civil violations rather than criminal misdemeanors.
  • House Bill 2037, proposed by Minority Leader Rep. Gene Ward (R), would let voters weigh in on the idea of a constitutional amendment to legalize adult-use cannabis. If approved, the amendment would allow lawmakers to implement an adult-use system, the report said.

Hawaii was one of the first states to legalize medical cannabis — and the first to do so via the legislature — but lawmakers have refused to go further on the issue despite growing national momentum for significant cannabis reforms. The Hawaii Senate voted overwhelmingly in favor of legalizing cannabis last year but that proposal ultimately died in the House.

A report published last year found that the state could generate more than $50 million in additional tax revenue each year by legalizing and regulating adult-use cannabis.

End


Maryland Bill Would Reinstate Traffic Stops and Searches Based on Cannabis Odor

Police in Maryland may once again be able to carry out traffic stops and conduct vehicle searches based solely on the presence of cannabis odor under a new proposal looking to reverse a legal change enacted last year, the Frederick News Post reports.

Lawmakers ended last year’s legislative session by adopting a law that prohibited police vehicle searches based purely upon an officer’s detection of cannabis by its odor.

The new bill, which is sponsored by State Rep. William “Bill” Folden (R-Frederick) and titled the Drug Free Roadways Act of 2024, seeks specifically to repeal “a certain prohibition against a law enforcement officer initiating a stop or a search of a motor vehicle based solely on the odor of burnt or unburnt cannabis.” The proposal also seeks to remove a provision that makes evidence from unlawful searches inadmissible in court.

Folden, who has a law enforcement background, told the Senate Judicial Proceedings Committee on Friday that his proposal highlights a matter of public safety and would safeguard against intoxicated drivers, the report said.

The bill is opposed by justice reform advocates including Yanet Amanuel, director of public policy for the American Civil Liberties Union of Maryland, who noted during Friday’s hearing that police historically used the smell of cannabis to justify racial profiling.

“Diligent law enforcement can and should be used to solve crime using honest initiatives and techniques without relying on pretextual bases such as the odor of marijuana for stopping and searching Black and Brown people.” — Amanuel, via the Frederick News Post

Maryland voters approved the state’s cannabis legalization measure in 2022 and adult-use sales were launched on July 1, 2023.

A 2021 survey of self-reported behavior found that cannabis legalization does not lead to an increase in cannabis-impaired driving.

End


AROYA: Optimizing Cannabis Cultivation With Cutting-Edge Software and Sensors

In the often tumultuous cannabis industry, cultivators face a myriad of challenges that make profitability an uphill battle. From grappling with unregulated markets and relentless competition from well-funded interests employing race-to-the-bottom pricing strategies, to navigating the complexities of federal illegality and dealing with a patchwork of ever-changing regulations, the journey for cannabis brands is far from straightforward.

However, where there are challenges, there is also innovation, and our industry is no exception. In response to these obstacles, a range of technological solutions has emerged to assist cannabis cultivators in their quest for success. One such solution is AROYA, a service designed to empower cultivators by optimizing their operations and increasing yields through the application of science and data. AROYA is a cannabis-specific offering from Addium, an AgTech (Agricultural Technology) company specializing in precision cultivation.

In this Spotlight, we delve into the world of Addium, its origins, and the context driving its mission. We had the privilege of sitting down with Scott Campbell, the CEO of Addium, to explore the applications of AROYA and the story behind the company’s commitment to enhancing the cannabis cultivation experience.

The Company

Addium was founded in 2022 in Pullman, Washington, located just near the state’s border with Idaho, in a region well-known for its agriculture. The roots of their story, however, trace back several years earlier. The vision to apply AgTech solutions to cannabis cultivation initially germinated during Campbell’s tenure at METER Group, another technology company based in Pullman that has offered scientific solutions to agricultural and industrial clients for decades.

METER Group was already developing solutions geared toward indoor cultivation, but Campbell noted that most of the applications were research-focused rather than agriculture-focused. The fact is, the current economics of international agriculture don’t financially justify indoor cultivation in areas where farming is difficult due to the environment, because it’s so cheap (albeit immensely wasteful) to import produce from overseas. Long-term, Campbell believes that indoor farming will become more common as it becomes more energy and cost efficient, and as climate change begins to have a more significant impact on agriculture around the world.

In the meantime, however, Campbell realized that cannabis was the first crop where it actually made financial sense to grow indoors, and while there were a variety of cannabis-focused equipment manufacturers and grow-monitoring systems that had been developed for growers already, none of them were using the combination of software and cutting-edge sensor technology that his company had to offer.

Washington was among the first U.S. states to fully legalize adult-use cannabis in 2012. After recognizing the opportunity, Campbell helped to spearhead the development of AROYA, a cultivation management platform specifically geared toward cannabis farming, which over time was adopted by licensed cultivation companies in numerous state markets – ranging from large-scale MSO’s to small and mid-size craft brands.

Although cannabis was legal in Washington, it was (and is) still federally illegal, which eventually led to disagreements within the parent company. Plant-touching operators are very familiar with how the stigma associated with their products can affect business relationships, and the ancillary businesses who cater to them often face similar obstacles. In this case, an amicable solution was reached: Campbell and his team would launch a new company called Addium with licensing rights to use the sensors and software for the cannabis industry and other specific applications. Today, Addium serves nearly 35,000 commercial clients and offers AROYA as one of its flagship products.

The Product

AROYA offers licensed cannabis growers a combination of software and hardware that work together to help optimize plant growth and maximize yields.

“There is a core belief behind everything we do at AROYA,” Campbell says. “Quality science = quality data = quality plants.” By having better insight into the numerous environmental factors affecting their plants, growers can more confidently make decisions about everything from irrigation, to lighting, to fertilization and harvesting. On top of that, AROYA’s software makes the management of all this data streamlined, and allows the operator to rapidly assess the current status of their crops at every stage, from vegetative to flowering and post-harvest.

Collecting all of this valuable data is the network of sensors that monitor the physical processes involved in cannabis growth and harvesting: irrigation, lighting, feeding, and processing. Campbell explained that while other software solutions geared toward cannabis cultivators tend to employ third-party sensors that were developed for larger-scale industrial agriculture, AROYA uses proprietary sensors designed specifically for precision farming, capable of taking much more accurate readings.

According to their website, AROYA’s line of proprietary suite of sensor technology includes:

  • A substrate sensor designed purposefully for cannabis that makes absolute comparisons between different growing media possible.
  • A climate station that allows growers to reliably monitor CO2, air temperature, relative humidity, as well as barometric and vapor pressure.
  • A full-spectrum quantum PAR sensor to provide accurate PAR measurements under all light sources, including LEDs.
  • An in-pipe EC sensor to measure the electrical conductivity of water in a pipe or tank, pairing with the substrate sensor to deliver a snapshot into the salts in your soil or substrate.
  • A moisture analyzer for use during the drying process, giving fast and accurate analysis of the moisture content and water activity of a sample.

Together, these sensors work in harmony with the software and environmental controls to allow for strategic crop steering as well as robust monitoring and enhanced control over every stage of the process. On top of all that, AROYA offers ongoing live customer support and consultation to help ensure that their clients are making the best use of their platform and to help custom-tailor workflows and data visualizations to each client’s unique requirements.

What kinds of cannabis farms use AROYA?

Campbell says AROYA has been implemented alongside virtually every type of cannabis cultivation methodology that exists, however the unifying trait among them tends to be operators who are obsessed with precision and tracking performance over time.

The key benefit of this data-driven approach is a consistent and predictable improvement in profitability per square foot per year, which Campbell says results in an effect similar to that of compounding interest: over time, a small but reliable increase in yield can add up to a very meaningful impact on a company’s bottom line.

The AROYA website features numerous case studies published about companies that have implemented their solutions, and one such brand is Node Labs, a cannabis breeder based in California that uses a scientific approach to provide cultivators with high-quality genetics. General Manager and Head of Cultivation for Node Labs, Cristian Ramos, said, “The major difference coming from traditional cultivation over to a science-based company with tissue culture and creating strains for cultivators is the necessity to be extremely disciplined with data collection and the standardization of practices.”

Another case study that underscores the impact of AROYA’s platform is its implementation at SHANGO, a cannabis brand with operations in Oregon, Arizona, Washington, and Nevada. Embracing AROYA’s advanced sensor technology, SHANGO has seen a remarkable 20% yield increase across their cultivation facilities. This success is not just confined to one location; the platform has enabled SHANGO to consistently enhance operations and decision-making processes across state lines. SHANGO’s Cultivation Manager, Greg Stefanik, highlighted the transformative effect of AROYA’s system on their ability to understand and optimize their operations, stating, “I had dreams of this… being able to graph out our cultivation data, review our history, and learn from each crop cycle. It’s like unlocking a new level of understanding.”

Conclusion

In a landscape marked by the complexities of federal illegality, fluctuating regulations, and fierce competition, AROYA offers an innovative approach for cannabis farmers to survive and thrive despite the obstacles they are forced to contend with. By combining their cutting-edge sensor technology and sophisticated software, AROYA has empowered cultivators to harness the power of data, adding another layer of value to their businesses and giving them a welcome advantage. And, in the current paradigm for licensed growers, every advantage matters greatly.

End


Germany’s Government Says Cannabis Legalization Deal Has Been Reached

Germany’s Traffic Light Coalition government — led by the Greens, the Social Democrat Party, and the Liberals — announced that a final consensus on the coalition’s plan to federally legalize cannabis was reached last week, according to a Forbes report. The agreement by the country’s leading coalition signals that a parliamentary vote is likely coming soon, with the legalization policy set to take effect on April 1.

The announcement comes just weeks after Germany’s health minister said he had high hopes that the nation’s adult-use cannabis legalization proposal would see a parliamentary vote this February.

Under the plan, personal cannabis possession and consumption by adults would be legalized, as would home cultivation. Cannabis sales would remain restricted but adults living in Germany will be able to register with private cannabis clubs starting on July 1, where cannabis distribution — but not consumption — will be allowed. The clubs will be limited to a maximum of 500 members.

The reforms were temporarily delayed by concerned members of the Social Democrat Party and due to international pushback, and the proposal was ultimately watered down last year to remove a provision allowing for blanket adult-use sales. Instead, lawmakers initiated a multi-year investigation into the implications of a regulated adult-use market with the possibility of enabling retail access at a later point.

Once enacted, Germany will be the third member nation in the European Union to legalize adult-use cannabis after Malta and Luxembourg. Additionally, many industry experts predict that cannabis reforms in Germany, which has the biggest economy in the EU, may inspire other EU members to follow suit with their own legalization policies.

End


Kentucky Lawmaker Files Cannabis Legalization Bill

Kentucky state Rep. Rachel Roberts (D) last week introduced an adult-use cannabis legalization bill to the Republican-controlled House of Representatives, according to the Louisville Courier-Reporter.

House Bill 420, as it is aptly named, would legalize cannabis possession and use for adults aged 21+ and establish a regulated industry for the cultivation, manufacturing, and distribution of cannabis products. Additionally, employers in the state would be unable to fire or refuse to hire someone for legally consuming cannabis, and people with cannabis misdemeanor convictions would be able to get their records expunged.

Roberts’ bill, which is co-sponsored by Rep. Keturah Herron (D), would also establish a new board in the Public Protection Cabinet that would take charge of the cannabis licensing process. The industry be taxed with a 9% excise tax on all cannabis sales, including retail and wholesale purchases, for at least one year, then the board would be able to establish a new tax rate.

Cannabis industry taxes and licensing fees would go into a “cannabis fund” with the state Treasury that fund the implementation and administration of the industry. For any leftover funds, at least 30% would be spent on addressing the negative impacts of cannabis prohibition, including by creating job training and re-entry programs for communities “historically targeted by drug law enforcement,” the report said.

The legalization proposal comes as Kentucky is working to launch its medical cannabis program, which lawmakers passed last year.

End


California Cannabis Grower Agrees to Pay $750K for Water & Wildlife Violations

The owner and operator of two Humboldt County-based cannabis cultivators, The Hills LLC and Shadow Light Ranch LLC, has agreed to pay $750,000 in fines and to take restorative actions after being accused of violating California state regulations protecting water and wildlife.

In a settlement approved by the Humboldt County Superior Court, Joshua Sweet — who owns and operates both cannabis grows — agreed to pay $500,000 to the Division of Water Rights, $175,000 to the North Coast Water Board, and $75,000 to the California Department of Fish and Wildlife (CDFW), according to a CDFW press release. Additionally, Sweet must obtain permits for his operations and take action to revert alterations to the water supply.

The restorations must be complete and the fines must be paid within five years, according to the settlement.

Sweet recently told CalMatters that he intends to “follow through with my end of the settlement” and that if the fines had been due immediately, “it would take everything I own.” Additionally, while Sweet recognized that his actions violated state law, he said he did not believe he was being treated fairly:

“Even during our court-mandated settlement conference, they were asked why they would go after a small independent businessman with these type of enormous fines usually reserved for huge corporations that destroy ecosystems.” — Sweet, in an email to CalMatters

The Hills LLC and Shadow Light Ranch LLC are based on 435 acres in The Emerald Triangle, a three-county region that is world-famous as an underground, frequently generational cannabis cultivation hub.

End


New Florida Bill Would Cap Adult-Use Flower at 30% THC, Concentrates at 60%

Florida lawmakers in the state’s House Healthcare Regulation Subcommittee last week advanced a proposal that would put a potency cap on adult-use cannabis products before the state has even enacted a legalization policy, the Tampa Bay Times reports.

The bill, HB1269, seeks a 30% THC potency cap for non-medical cannabis flower products and a 60% cannabis potency cap for extracts and concentrates. Edibles, meanwhile, would be capped at a max of 10 milligrams of THC per serving and 200 milligrams per package. The proposal would only take effect 30 days after the passage of an amendment legalizing adult-use cannabis.

Notably, the Florida Supreme Court is currently considering whether to allow such an amendment to appear before voters this year after the attorney general asked the court to reject an initiative brought by advocates who had collected nearly a million voter signatures supporting the reforms.

Gov. Ron DeSantis (R) — who does not support the legalization of cannabis — said recently that he believes the court will allow voters the chance to consider the issue this November.

One of the bill’s co-sponsors, Rep. Ralph Massullo (R-Lecanto), said that the bill — despite being designed to preempt a voter-backed legalization decision — doesn’t infringe on voter rights.

“This gives them an opportunity to understand that if recreational marijuana passes in our state, whether the likelihood of that is high or low, that they will know that the legislature will step in to protect the public.” — Massullo, via the Tampa Bay Times

With the 13-4 vote, the bill has passed its first committee hurdle while on its way potentially to the House floor. The proposal does not have a companion bill in the Senate, the report said.

End


Looking out the passenger window of a moving car.

Study: THC Blood Levels Do Not Correlate With Impairment

In a recent study published in the Journal of the American Medical Association (JAMA) Network Open, researchers have taken a closer look at the effects of cannabis on driving abilities, particularly focusing on older adults aged 65 to 79 years. The study, led by Patricia Di Ciano, PhD, alongside a comprehensive team of experts, delves into the nuanced relationship between the consumption of cannabis, its impact on driving performance, and the amount of THC found in participants’ blood.

In summary, the authors noted that although the evidence suggested cannabis use could impact driving performance, “blood THC level was not correlated with driving behavior.”

The study’s participants, who were regular users of high-potency THC-dominant cannabis, demonstrated an increase in weaving and a decrease in speed 30 minutes after consumption. However, these changes in driving performance were not directly correlated with blood THC concentrations. Impairment seemed to fade within a few hours of consumption, with the authors noting “the associations between cannabis and driving were apparent at 30 minutes but not 180 minutes after smoking.” Interestingly, self-reports of impaired driving persisted for 3 hours, indicating a heightened awareness among participants of their potential impairment.

In response to the study, NORML released a statement calling for more sensible regulations around cannabis impairment.

“That conclusion is consistent with numerous studies reporting that neither the detection of THC nor its metabolites in blood and/or other bodily fluids is predictive of impaired driving performance. As a result, NORML has long opposed the imposition of per se THC limits for motorists and has alternatively called for the expanded use of mobile performance technology like DRUID.”

– Excerpt from NORML’s statement

DRUID is a mobile app produced by Impairment Science, Inc. that uses “neuroscience to assess a user’s level of cognitive and motor impairment,” according to their website. The app can be used by individuals to determine their own impairment, as well as used for numerous business applications. It was implemented in 2021 by the Department of Public Safety in Highland Park, Texas, to track officers’ fatigue levels and help determine optimal shift schedules.

Considering that THC blood tests are currently used by most law enforcement agencies to determine if drivers are under the influence, the lack of a clear correlation between this variable and driving performance challenges the effectiveness of these regulations and highlights the need for a more nuanced approach to determining impairment.

End


New York Gov. Blasts Cannabis Industry Roll-Out as New Lawsuits Seek to Delay Licensing

The roll-out of New York’s adult-use cannabis industry has been “a disaster,” Gov. Kathy Hochul (D) said last week in an interview with Buffalo News.

Hochul said that while she agrees that cannabis legalization is “the right policy,” the state took too long to launch legal sales. This ultimately gave the unregulated market significant advantages over early licensees. She also said that officials have little resources or “teeth” with which to pursue and punish unlicensed retailers, which have only flourished since cannabis prohibition was lifted by lawmakers in 2021 — and which officials say put the state’s cannabis consumers at risk.

“It’s not every street corner, it is every other storefront. It is insane.” — Hochul, via Buffalo News

The governor’s criticisms followed a recent incident where officials were only prepared to issue three new cannabis industry licenses despite the expectation that hundreds of licenses would have been awarded by now.

The industry’s roll-out has largely been delayed due to lawsuits against the state’s social equity- and lottery-based licensing system, including a lawsuit by military veterans who argued they were being wrongfully excluded from the social equity licensing process.

Hochul’s harsh words turned almost prophetic this week following the announcement of several new lawsuits against the state’s licensing process, according to Green Market Report.

The latest suit was filed this week by seven women-owned, social equity cannabis companies who claim that the “randomized queue” being used by lawmakers is “arbitrary and capricious,” and that certain inconsistencies — one licensee, for example, was found to have an extra entry in the queue — suggest the system is fundamentally flawed.

In another lawsuit filed on January 24, plaintiff Valencia Ag LLC argues that the state’s licensing preferences for minority and/or women applicants violate the U.S. Constitution by giving “disfavor to white men.”

End


Andrew Maltby Portrait, Predatory Mites Closeup

Andrew Maltby: Raising Predatory Mites for Integrated Pest Management

Andrew Maltby is the President and owner of Biotactics, a company at the forefront of offering integrated pest management solutions. Based in California, Biotactics specializes in breeding predatory mites to help defeat agricultural pests like the widely-loathed spider mite, as well as helping cannabis cultivators prevent and respond to infestations. In this Q&A, Andrew joins us to discuss:

  • How Biotactics raises “insatiable” mites that eat much more than typical predatory mites
  • Why it’s important to deploy predatory mites as soon as possible once they’ve been cultured
  • What Big Agriculture could learn from living soil cannabis cultivators
  • How different growing environments can affect infestation risk
  • And much more

For the full interview, continue reading below!


How did you get into the business of raising predatory mites?

I actually get asked that quite often. The short answer is that I took over Biotactics after my father retired in 2013. The long answer would be how my family got into the business. That is a story for another day. My family was trained by the founder Glenn Scriven, who was a respected researcher at UC Riverside and a renowned pioneer in the IPM world.

My first stint working at the company was in 2006. I took the summer and fall semesters off from SDSU and worked at Biotactics. My father had just fully implemented our new method of obtaining the pure spider mite eggs. I was tasked with making it predictable, efficient, and basically perfect. At that point, I was about to be a senior in Chemistry major so my lab hands were on point. I spent the whole summer testing exactly what 10, 20, and 30 spider mite eggs per predator would yield. That was when I discovered that there was a possibility to double our culture quantities every 24 hours. Now, that is common practice for us.

What’s behind the name “Benemite” – and what makes them unique?

The Benemite trademark was Glenn’s idea. It is a portmanteau of “beneficial mite.” The mascot used to be a predatory mite with a cape on. That was “mighty mite.” I kept the trademark to signify which predators are reared using our superior food source: spider mite eggs.

To understand what makes Benemite predators unique, you must know how every other insectary raises theirs. Outside of Biotactics, Persimilis is reared the same way. Bean plants are planted, grown, infested with spider mites, they reproduce, then the plant is infested with Persimilis, and they eat and reproduce until there is no food (spider mites) left. Persimilis is known to habitually climb upward in search of food, so they do just that, then they get stuck in a container hanging at the top of the plant. They are starved off the plant, collected, weighed, then shipped to the US from Europe or Africa.

Every other species of predatory mite is reared on what is called a “factitious food source.” These are usually a type of mold mite. If you have ever looked at the contents of a sachet under the microscope then you have probably seen these slow, hairy mini monsters. The spider mite egg is the most nutritious life stage of the most nutritional prey mite. It does not try to run away like the mobile stages, so the youngest predators always have the best food source possible right in front of them.

Biotactics serves cannabis farmers as well as farmers of berries and other agricultural products. How do pest issues with cannabis growing differ from those encountered when growing other crops?

If you want to hear about the problem I had with major insecticides, see the top pinned video on my Instagram page @biotactics. It explains why predatory mites never made it into major farming. (Hint: Neonics make spider mites toxic to predators.)

Pest issues in “Big Ag” are almost worse than in cannabis because the entire monocrop system is built on chemicals. It is ingrained in the culture so much that agronomy students primarily learn which chemicals to use and when. They are taught to fumigate the soil, killing off any beneficial microbes that could be there. Then they need to band-aid over the damage done to the soil with chemical fertilizers. Then they plant seeds treated with systemic fungicides, systemic neonicotinoids, and even more chemical nitrogen.

The pest control practices they are taught are just chemistry lessons, like which chemicals can be mixed with others or sprayed on their own. Instead of fixing the problems created by chemicals, they are taught about which new chemicals fix a given problem that was caused by chemicals used earlier in the season.

It’s not the farmers’ fault that they have been deceived for decades and decades. They need to unlearn generations of education. I do think Big Ag could learn a lot from the cannabis producers I work with. Many cannabis growers are less apprehensive to the idea of introducing more bugs to their crops. They are already familiar with the idea that more life in your mini ecosystem is better than trying to make a clean room in the dirt. We would not have to worry about losing our bees if much of our farmland was switched to living soil.

How do the risks for growers differ based on whether their grow is indoor vs. outdoor, or which medium they use?

Every environment comes with its own challenges. Scouting every day or every other day is the absolute best way to catch a pest issue early. I also recommend small, preventative releases every 2-3 weeks. This way you don’t have to scout as often, and you can let the predators hunt into the hard to reach places.

Outdoor grows seem to have the most resilient plants that I have seen, but then again, they live outdoors so there is always the risk of multiple pests infesting at once. Growers should always attempt to release predators that are native to the area so they can reproduce and overwinter for long term benefits.

Early in the season, the pests are still overwintering so it’s smart to release beneficials like N. Fallacis and Stratiolaelaps that are naturally adapted to cooler climates. Indoor is usually very chemical focused which can lead to a population of what I call “frankenmites.” These are pest mites that are resistant to anything you throw at them, except getting eaten. Even when you rotate sprays you still get resistant populations. Spider mites are especially notorious for this. They have an uncanny ability to develop resistance to chemicals. People say cockroaches will still be alive after a nuclear war, and I think spider mites will be right there with them.

What is the worst-case pest infestation scenario a grower can be exposed to?

Worst case that I have ever seen: severely taco’d leaves that were connected by webbing. They looked like a hotdog with webbing as the condiment. They had a disturbingly large amount of russet and spider mites throughout their entire greenhouse, and they were only three weeks from harvest. That was a memorable day because it was the first time I had ever told a grower that it is unfixable. I ended up using some of his leaves to take some really awesome pictures of our predators attacking russet and spider mites. Shoutout to Erik.Nugshots for coming to the farm that day.

When you’re helping a cannabis grower address a pest infestation, at what point does Biotactics typically get involved? Do you help diagnose the problem, and if so, is this done virtually or in-person?

Great question! I have done quite a bit of online diagnoses using all the same tech that allows people to work remotely, although I always prefer to see large grows in person. It is fun to see the before and after with my own eyes. This happens often via DM through our Instagram page. Sometimes I catch things they don’t see just through experience, other times the webbing gives it away.

I recommend the proper predator(s) once we have nailed down the pest, then I come up with a release rate based on the stage of infestation. I know exactly how many spider mites my predators eat every 24hrs because I know exactly how much I feed them. Other pest mites like russets and broads required testing before I could confidently give a recommendation. This same testing is what taught me that G. Occidentalis can control and reproduce on the Hemp Russet Mite. Still waiting on someone to publish that research though.

What are some of the benefits of locally-raised predatory mites vs. mites shipped from overseas?

We are the only insectary that rears 100% of its predators in the US, in Southern California specifically. This is something we are very proud of. Our growers release our predators within 48 hours of when they leave our cultures. We also require our distributors to send dropship orders: this way it goes straight from us to the grower.

With that said… The main problem with intercontinental transport is the fluctuations of temperature and humidity between when they are packaged at the insectary to when they get released on the end-user’s crop. First they get driven to the airport, dropped off, shipped in the cargo hold of an airliner, then there is usually a several hour long layover, they arrive at the final airport, off-loaded with all the other cargo, transported to a USDA inspection facility, released to the insectary representative, repackaged, then sent to the end user or another distributor who again ships them to the end user. That is four days minimum.

Be wary of sources that have predators on-hand because they most likely have stored them for days already. “Breeding” or “slow-release” sachets make that entire trip with a hole already in the bag. Our healthy predators would have lined the inside of the box before the first plane took off.

Most growers in the US are releasing Persimilis that have gone without food for 4 to up to 10 days. That is why they act so crazy when growers open the bottles. They are literally starving to death. All that time without food causes permanent damage to their reproductive ability. Even in their ideal climate, if predatory mites can’t lay eggs, then they don’t eat. Their field efficacy reflects that biological change.

How do you measure the effectiveness of the mites that you raise? Have you compared their performance to other predatory mites that are on the market?

Two years ago, I donated some of our Benemite Fallacis to a major university entomology lab that was testing a new fungicide on strawberry plants with spider mites. They were testing its effect on various samples of predatory mites. The head entomologist ended up having to re-do the entire experiment because our Fallacis ate all the spider mites in the field so there were none left to keep the other predatory mites around. She said she had never seen anything like it. “They’re insatiable,” she said. So, that was fun.

The best way to determine the efficacy of predatory mites is with the “egg-to-egg” test. Predatory mite eggs are about half the size of their body, and type I’s and II’s can lay up to 5-6 eggs per day. They must eat a whole lot of nutritious food every day in order to do that.

We start with a fixed number of freshly laid predator eggs, usually 10 or 15, of the same species from our insectary and some from another source. Each insectary has its eggs on their own culture tray in the ideal reproductive climate for the species we are testing. We put a very small amount of spider mite eggs near the eggs so when they hatch into nymphs, they have food right away. We keep them fed well throughout the test. We remove the males once they molt into adults and all the females have been fertilized.

Now we have our first data point: the Male to Female ratio. In the wild, this ratio is one male to every three females. However, when food is scarce or poor quality the ratio can be flipped. We have seen this in many samples from every other insectary, especially with Californicus and Persimilis raised on factitious food sources. That is bad for the growers because healthy female predators eat +3x as much food as the males. Every single Benemite species are 75-78% female every single time we have tested them.

Our second data point: the eggs laid per day by the females left on the tray. We count them by removing them from each tray every 16-20 hours. These results are always hard to believe, and I know every other insectary has done these tests internally but will never release the data. On average our Benemite females lay 5 eggs per day. The female predators raised on factitious food sources laid an average of 0.5 eggs per day, or one egg every other day.

Currently, the regulations governing cannabis growing differ widely from state to state. Looking ahead to a US policy landscape that allows for interstate commerce, how do you think pesticide rules will be affected, and how might a federally-governed regulatory structure differ from what we see at the state level?

While I sincerely hope that the cannabis testing standards stay as high as they are, I am worried that federal legalization will allow it to be lumped in with the rest of agriculture. The agrochemical companies hold a massive amount of power in Washington DC and they have corrupted the governments in the most ag-centric states, even here in California.

Look at California strawberries. They frequently top the “Dirty Dozen” list of pesticide laced foods. The farmers have been lied to for decades under the guise of scientific “research,” though those projects were mostly funded by the same agrochemical companies the “research” promotes. These same companies are directly connected with the pharmaceutical companies, who are creating what many see as human pesticides. Or they make medicine to counteract the symptoms caused by their agrochemical sector.

I think cannabis’ saving grace is the growers themselves. Long-time growers have always been skeptical of the government propaganda, and they know the plant better than any regulator ever could. Their standards are already higher than any test required by law. These pesticide regulations are not for the growers I work with, they are for the growers that struggle to grow literal tons of mids.

My one hope is that systemic insecticides like neonicotinoids will never be legal in any version of cannabis production. Even commercial hemp. Not only are they ineffective against spider mites, but they also make spider mites severely toxic to natural predators. I discovered that the hard way.


To learn more about the predatory mites raised by Biotactics or get in touch, visit their website.

End


Michigan Cannabis Dispensaries Set $3B Sales Record In 2023

Cannabis sales in Michigan hit a record high last year with dispensaries retailing a little more than $3 billion worth of cannabis, the Metro Times reports.

Annual cannabis sales have increased every year since Michigan’s adult-use market launched in 2019, and a significant majority — about $2.74 billion — of last year’s sales were from adult-use transactions. Notably, retailers closed out the year with the state’s highest monthly cannabis sales record to date with $279.9 million in December sales.

The record sales year also generated about $457.6 million in new taxes for the state — including more than $274 million for local governments, schools, and roads, with an additional $183.6 million for schools, roads, and public health, the report said.

Despite the substantial amount of local tax dollars that cities could gain from cannabis sales, a majority of the state’s municipalities have adopted moratoriums against adult-use sales.

Michigan voters approved the state’s cannabis legalization reforms in 2018 and adult-use sales launched in the state in 2019. The market has been plagued from its start by issues with oversaturation, which caused retail prices to plummet from a little more than $500 per ounce of cannabis flower at market launch to just $80 per ounce last January. Average prices increased slightly over last year, ending at about $90 per ounce in December, according to the report.

State officials in Michigan, which was the 10th U.S. state to legalize adult-use cannabis, opted last year to remove cannabis-related drug testing restrictions for most state employee positions.

End


Texas Sues Cities Over Voter-Approved Cannabis Decriminalization Policies

Texas Attorney General Ken Paxton (R) announced on Wednesday a new lawsuit by his office against the five Texas cities that have passed cannabis decriminalization policies, The Hill reports.

The lawsuit names city mayors and council members from the five cities, which include Austin, Denton, Elgin, Killeen, and San Marcos, and argues that officials have adopted amnesty and non-prosecution policies “that violate Texas laws concerning marijuana possession and distribution.” The lawsuit further states that the cities’ decriminalization policies — all of which stem from successful voter initiatives — are illegal under the state constitution, which prohibits municipalities from enacting ordinances that are inconsistent with state law.

“I will not stand idly by as cities run by pro-crime extremists deliberately violate Texas law and promote the use of illicit drugs that harm our communities. This unconstitutional action by municipalities demonstrates why Texas must have a law to ‘follow the law.’ It’s quite simple: the legislature passes every law after a full debate on the issues, and we don’t allow cities the ability to create anarchy by picking and choosing the laws they enforce.” — AG Paxton, in a press release

Voters from a sixth Texas city, Harker Heights, approved cannabis decriminalization alongside others named in the suit during the most recent midterm elections, but the city council there ultimately repealed the initiative, the report said.

Notably, city council members in Lubbock recently rejected a cannabis decriminalization proposal, which prompted the issue to be kicked to voters during the election later this year.

End


2024 industry predictions for cannabis products, retail, and hemp

2024 Cannabis Industry Forecast: Product Brands, Retail, and Hemp

As the cannabis industry continues to evolve, 2024 promises to be a year of significant change, from product development, to retail dynamics, as well as in the hemp/CBD market. Over the past few weeks we put out a call for commentary to our newsletter audience, asking industry professionals and business owners to share their expectations for the coming year. Below, we have rounded up some of the most insightful comments we received, forecasting what could lie ahead for these sectors.

A common theme among the predictions we reviewed was a belief that demand for product personalization and increased consumer awareness will have a significant impact on the market landscape, forcing cannabis brands, dispensaries, and hemp/CBD manufacturers alike to diversify their offerings. The broad consensus is that consumers are likely to care more about craft and high-quality products the more educated they become, meaning that over time it will be less advantageous for brands to focus on volume and market share alone. The potential for new AI technology to affect all aspects of the cannabis supply chain was also a recurring theme, as was the rising popularity of hemp and cannabis-infused beverages.

Cannabis Product Manufacturing & Cultivation

In 2024, craft cannabis is poised to claim a larger slice of the expanding global market, driven by a growing consumer appetite for quality, uniqueness, and sustainable practices. Artisanal producers are set to thrive, leveraging horticultural science methods and distinctive strains to meet the desires of an increasingly sophisticated clientele. Illinois exemplifies this trend, leading the industry with robust regulation that upholds high standards and prices, potentially benefiting small-scale, premium craft cannabis ventures. However, such stringent oversight may also challenge craft entrants financially, underscoring the need for regulatory frameworks that nurture the artisanal segment. Craft cannabis’s success will depend on navigating these regulations while delivering the exceptional products that discerning consumers demand.

Owen Papworth, COO Oregonix


We will continue to see innovation and a shift in products on shelves, particularly in the edibles space. Consumer expectations for “premiumization” and the ongoing momentum in social “mainstreamization” will collide, bringing an eruption of new, innovative products to the market that are effective, friendly, and predictable. Cannabis products that are approachable and easy to use for every (adult) generation and every social and wellness application will become the new normal.

Kim Sanchez Rael, CEO & Cofounder Azuca


Product innovation is going to continue to proliferate as new markets open up, existing ones expand to adult use and more and more consumers, from all walks of life, start buying. These opportunities will be seized by the individuals and cannabis operators that have solid plans and a network of providers that will work with and support their business to not just open their doors but keep them open and successful as they grow.

Kevin Hart, CEO Green Check


Bottom up, AI will revolutionize the cultivation process by facilitating efficient plant cultivation, optimal crop steering, and targeted breeding. Cultivation operations will be able to reliably forecast and plan their production, maximizing the achievable prices and, thus, their profitability. […] Like with any other technological advances, the job landscape will evolve as well and certain jobs will fade out, others will transition, and new jobs will emerge – the most important aspect is that the workforce and the leadership embrace the change to not be left behind.

Elmar Mair, CEO Neatleaf


Brands that solely focus on low-quality, budget pre-roll offerings will continue to decline. Harsh joints kill recurring revenue; nobody comes back to a bad smoke. With their galaxy of opportunities for differentiation and added margins, infused joints will continue to overtake non-infused joints in markets where that hasn’t already happened. Smaller-size joints will continue to grow in popularity, and the convenience and value of multipacks will continue to edge out single-joint offerings. To grow in 2024, brands should strongly consider combining all four: high-quality flower, .5g or smaller, infused-joint multipacks at an approachable price.

Kyle Loucks, CEO RollPros


Retail Business & Consumer Awareness:

Minnesota is well on its way to creating a “heady” cannabis culture with savvy, informed consumers. Before legal cannabis sales start, Minnesota has already allowed adults to purchase cannabis seeds and grow their own cannabis at home. It’s currently one of Royal Queen Seeds’ biggest markets for online sales, so we can see the potential there and the curiosity from consumers. With the ability to grow their own at home, the canna-curious and connoisseurs alike can develop a deeper understanding of the cannabis plant, gain a new appreciation of the natural world and become smarter shoppers overall.

Shai Ramsahai, President Royal Queen Seeds


In the New York market, the settlement of the lawsuit blocking CAURD dispensary licenses from opening, which was incredibly painful for those licensees and the broader market, means that operators can now finally move forward with opening their stores. We are seeing an eightfold increase in the pace of openings from the previous average of two stores per month; however, this is still not nearly enough for a state of roughly 20 million people and over 250 million tourists annually. However, also worth noting is the planned openings of licensed adult-use retail stores by MSOs which previously only held medical licenses. New York’s farmers and producers of any size need more retail stores to sell their products, so I believe these co-located stores will be very important. At this point, New York needs about 200 stores for the legal market to reach its intended revenue projections.

Nicolas Guarino, CEO Naturae


In 2024, dispensaries and brands will realize their target audiences aren’t spending their time networks that are a constant detriment to their growth, like Facebook or Instagram. Alternative networks like Reddit and Discord will give cannabis companies a way to interact and build communities with true connoisseurs.

Amy Donahue, Owner Hybrid Social


The integration of AI-enabled tools will revolutionize training and ongoing worker engagement processes, making them more accessible, interactive, and tailored to individual needs. This personalized approach to learning will not only enhance workforce readiness but also ensure compliance with evolving regulations. The focus will shift towards micro-certifications and scenario-based learning, enabling employees, especially budtenders, to adapt quickly to market changes and product innovations. Furthermore, enhanced communication tools, including AI-driven interactions, will foster more dynamic and responsive relationships between brands, service providers, and licensed employers. This will lead to a more informed and engaged community, capable of elevating customer experiences.

Mark Oronzio, CEO and Cofounder upLVL, Inc.


We expect to see a contraction of the legal market in California as retailers and suppliers cease operations or leave the state. We have experienced this with several brands who have chosen to stop operating in CA because of the never ending black market, compliance costs and competition from the oversaturation of licensed businesses. Many retailers are struggling to pay taxes and other compliance costs, while customer counts and the average purchase per customer continues to decline due to outside economic factors and too many operators in mature markets like San Francisco and Los Angeles. We also expect to see fewer independent retail operators as larger companies expand by acquiring legacy licenses, and smaller companies struggle to operate profitably.

Lauren Fontein, Co-Founder The Artist Tree


A notable trend is the rise in demand for personalized cannabis products, including a focus on cannabinoid therapeutics​​. THC-infused beverages are also gaining popularity, with consumers often replacing alcohol with these products​​. Retailers that prioritize consumer education, experience, evolving preferences, and specific needs are likely to fare better than those mainly motivated by profits. This approach supports a consumer base seeking a tailored and informed cannabis experience.

Sonia Mangalick, Managing Partner Dank Poet Dispensary


Trends in Hemp & CBD-Infused Products

In 2024, we anticipate substantial growth in the hemp industry, especially in low-dose beverages and edibles. Minnesota’s pioneering hemp-derived market model is setting a trend nationwide, expanding product variety for a wider consumer base and integrating cannabis products more seamlessly into mainstream culture. However, it’s crucial that the hemp-derived market not be seen as a substitute for the legalization and regulation of adult-use cannabis. This year is pivotal for policy decisions that will define the relationship between these two markets. While the hemp market broadens consumer reach and aids in destigmatizing cannabis, true social equity hinges on the legalization of adult-use cannabis. This is vital for addressing the needs of communities disproportionately affected by prohibition and those involved in the legacy market. Policy choices made in 2024 will be instrumental in determining the future direction of both markets, significantly impacting public perception and advancing social justice within the cannabis industry.

Leili Fatehi, Partner/Principal Blunt Strategies


Pressures to regulate will slow the hemp CBD market. Synthetic conversions of hemp CBD to THC will get more attention to regulate vs. stop.

Shawn DeNae Wagenseller, CEO/Owner Washington Bud Company


Cannabis products have been diversifying beyond traditional flower and oils. Expect to see more innovative products, including edibles, beverages, topicals, and concentrates. Cannabis-infused products in the wellness and beauty industries might also see growth. As more research is conducted, there may be an increased acceptance of cannabis as a medical treatment for various conditions, potentially leading to more doctor recommendations and insurance coverage for medical cannabis.

Katie Enright, Founder Lavinia


In 2024, hemp beverages will do more to normalize cannabis in the minds of the consumer than any other form factor.

Kenny Morrison, Founder CQ


We foresee the continued rise in popularity of low-dose infused beverages. And we aim to further accelerate this trend, anticipating increased backing from liquor retailers, beverage distributors and a fresh wave of mainstream consumers. Our collective hope is to usher in a cultural turning point where regulations are thoughtfully crafted to provide a sensible framework for this category, rather than seeking its elimination.

Phil McFarland, General Manager, THC Beverages WHBCo


Consumer empowerment takes center stage as products become more tailored to individual needs. The industry will witness a shift from one-size-fits-all to customizable CBD experiences. Brands offering personalized solutions will resonate with a diverse and discerning consumer base.

Jakub Horák, Founder TOKE

End


Senate Democrats Urge Biden to Deschedule Cannabis

Twelve Senate Democrats this week called on the Biden Administration to remove cannabis from the Controlled Substances Act (CSA) in a letter to the federal Drug Enforcement Administration (DEA), according to an NBC News report. Cannabis has been considered a Schedule I substance, since 1971

“The case for removing marijuana from Schedule I is overwhelming,” the letter argues. “The DEA should do so by removing cannabis from the CSA altogether, rather than simply placing it in a lower schedule.”

The senators’ call for the complete removal of cannabis from the federal drug schedule comes following a recommendation by the Department of Health & Human Services (HHS) that cannabis be moved from Schedule I to Schedule III under the CSA. The DEA has since argued that it should have the final say regarding the federal status of cannabis.

The letter, led by Sens. Elizabeth Warren (D-MA) and John Fetterman (D-PA), carries the signatures of Senate Majority Leader Chuck Schumer (D-NY) and nine other senators.

“The Biden Administration has a window of opportunity to deschedule marijuana that has not existed in decades and should reach the right conclusion — consistent with the clear scientific and public health rationale for removing marijuana from Schedule I, and with the imperative to relieve the burden of current federal marijuana policy on ordinary people and small businesses.” — Excerpt from the letter by Senate Democrats

Meanwhile, President Joe Biden (D) stands to see his voter approval ratings potentially increase by up to 11% if he were to follow the HHS recommendation to reschedule cannabis, according to a recent survey.

A recent Gallup poll recorded 70% support among Americans for legalizing adult-use cannabis, an all-time high for the pollster since it started posing the question more than 50 years ago.

End


Ohio Cannabis Regulators Release Adult-Use Industry Draft Rules

Ohio cannabis regulators this week released the draft rules for the state’s adult-use cannabis industry that was approved by voters last year. Officials are also asking for public feedback on the proposed rules, which outline application costs and detail the state’s plan for a lottery-based licensing system.

Under the proposed rules, medical cannabis retailers would be able to apply for a dual-use license — which enables serving both the medical and adult-use cannabis markets — at no additional cost. Meanwhile, vertically integrated companies in the state including Level 2 and Level 1 cultivators would be granted respectively either one or three retail licenses. Applications for new dispensaries in the state will cost $5,000 for either an adult-use or dual-use license. License renewals would be priced at $200,000 for Level 1 cultivators, $50,000 for cannabis processors, and $20,000 for Level 2 cultivators and cannabis testing labs.

Officials also confirmed their intent to hold an application period “for which preference shall be given to applicants certified as cannabis social equity and jobs program participants,” which was a requirement of the legalization initiative passed overwhelmingly by voters last year.

Notably, cannabis dispensaries in the state will be required to maintain a one-mile buffer between themselves and other cannabis retailers.

Members of the public are invited to submit feedback on the draft rules to officials through February 9. Applications will be available by June 7 with provisional licenses to be awarded by September 7.

A report published ahead of November’s election found that legalizing adult-use cannabis in Ohio would likely generate about $260 million in “net benefits for society.”

End


Cannabis Retail Bill Advanced By Virginia Lawmakers

Lawmakers in a Virginia Senate committee last week advanced a bill that would establish an adult-use cannabis marketplace in the state, the Washington Post reports.

The Senate Committee on Rehabilitation and Social Services passed SB 448 in a 10-5 bipartisan vote but the bill still needs to pass several more committees before reaching the Senate floor. If adopted, the bill would put into motion the regulation of cannabis manufacturing and distribution, with adult-use sales to launch in Virginia by January 1, 2025.

Proponents of the bill say that regulating adult-use cannabis is a commonsense step forward following the state’s legalization of cannabis three years ago and that licensed sales would reduce the risk of exposure to contaminated products.

“We already have a $3 billion adult-use cannabis market. It’s just being run by drug dealers who are selling untested, unlabeled, untaxed products. We are not creating the market. We are regulating the market.” — Greg Habeeb, lobbyist for the Virginia Cannabis Association, via the Washington Post

Lawmakers are still uncertain, however, how the bill would fare before Gov. Glenn Youngking (R), whose administration stated last year that the governor had no plans to facilitate adult-use cannabis sales while he is in office.

“This is an area that I really don’t have any interest in,” Youngkin told reporters earlier this month. “There’s so many things that we can work on that I think we can get to the finish line and … I just don’t have a lot of interest in pressing forward with marijuana legislation.”

Numerous studies, including a recent CDC analysis, have suggested that having a regulated adult-use cannabis market does not lead to an increase in underage cannabis use; rather, it may reduce teenagers’ access to cannabis.

End


Arkansas AG Rejects Cannabis Ballot Initiative

Arkansas Attorney General Tim Griffin has rejected the initial language for a ballot initiative that would improve medical cannabis access and trigger adult-use legalization in the state if cannabis were ever legalized at the federal level.

First reported by the Arkansas Advocate‘s Hunter Field, Griffin on Monday rejected the Arkansas Medical Cannabis Amendment of 2024 and ruled that the initiative contained improper formatting and ambiguities about how the initiative would affect current laws. Advocates behind the ballot initiative say that they intend to address the issues raised by the attorney general and then resubmit the proposal.

The ballot initiative, which is supported by the state’s medical cannabis industry, proposes several significant reforms to the state’s medical cannabis program, including:

  • Allowing registered patients to grow their own cannabis plants at home.
  • Allowing nurse practitioners and other health providers to recommend patients for the program.
  • Allowing providers to certify anyone they see fit for the program.
  • Allowing for telemedicine medical cannabis referrals.
  • Recognizing out-of-state medical cannabis patient ID cards.
  • Removing program application fees for patients.
  • And increasing the program’s registration period for patients from one to three years.

Additionally, the ballot initiative would trigger the legalization of cannabis possession by adults were the federal prohibition of cannabis ever repealed.

If a reworked version of the ballot initiative is accepted by the attorney general, advocates will have until July 5 to gather 90,704 signatures from registered voters to qualify for the ballot.

Arkansas medical cannabis retailers sold about $283 million worth of cannabis products last year.

End


Connecticut ‘Loophole’ Allows THC Beverage Sales In Liquor Stores

Some Connecticut liquor stores and other markets have started selling THC-infused seltzers under a “loophole” relating to product serving sizes, according to a CT Insider report.

Under state law in Connecticut — where cannabis was made legal in 2021 and later became available for purchase by adults in January 2023 — cannabis consumables including flower products, concentrates, and infused edibles and beverages are only available for purchase via state-licensed dispensaries. But lately, some THC-infused seltzer products are also being retailed in other markets including convenience stores and state-licensed liquor stores following adjustments to the products’ listed serving sizes in what insiders are calling a “loophole” in state law, the report said.

Per a Connecticut Department of Consumer Protection spokesperson, “a package containing less than 1 milligram of THC per serving and less than 5 milligrams per package is not considered cannabis, and may be produced and sold without a license.”

Some manufacturers, according to the report, are taking advantage by creating products that contain fewer than five milligrams of THC overall and labeling them as being more than five servings, regardless of the product’s volume (typically 7.5 or 12 ounces).

State Rep. Michael D’Agostino (D) said that lawmakers are planning to address the loophole by reducing the THC limit for retail products sold in the state without a cannabis license to .5 milligrams per container.

“This is constantly evolving, and we realized as a committee that we’ve got to get further ahead of this so that’s why this session we’re going to be changing that definition to make it even just a more bright line rule.” — D’Agostino, via CT Insider

Connecticut regulators recently doubled the cannabis purchasing limits from 7 to 14 grams per transaction.

End